ResearcherThe University of Texas MD Anderson Cancer CenterActive in the last 2 years
Phillip Andrew Futreal
Matched on ORCID iD 0000-0001-8663-2671; OpenAlex author ID A5067102201; NIH RePORTER profile ID 9444957. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 1
- Labs led
- 0
- Collaborators
- 39
2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: 1 paper · 2019: none · 2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: 1 paper · 2025: 1 grant
Papers 4
- Clonal dominance defines metastatic dissemination in pancreatic cancer. Co-author DOI 10.1126/sciadv.add9342↗
- Germline DNA Sequencing Reveals Novel Mutations Predictive of Overall Survival in a Cohort of Patients with Pancreatic Cancer. Co-author DOI 10.1158/1078-0432.ccr-19-0224↗
- High Prevalence of Hereditary Cancer Syndromes and Outcomes in Adults with Early-Onset Pancreatic Cancer. Co-author DOI 10.1158/1940-6207.capr-18-0014↗
- Identification of double-stranded genomic DNA spanning all chromosomes with mutated KRAS and p53 DNA in the serum exosomes of patients with pancreatic cancer. Co-author DOI 10.1074/jbc.c113.532267↗
Grants 1
Closest collaborators
The 25 strongest of 39 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Anirban Maitra · 2 shared papers, 1 shared grant, 2018–2025 · strength 0.65
- Raghu Kalluri · 1 shared paper, 1 shared grant, 2014–2025 · strength 0.49
- Cyril Henri Benes · 1 shared grant, 2025 · strength 0.45
- Gerald C Chu · 1 shared grant, 2025 · strength 0.45
- Ronald Anthony Depinho · 1 shared grant, 2025 · strength 0.45
- NABEEL El-BARDEESY · 1 shared grant, 2025 · strength 0.45
- Ralph Weissleder · 1 shared grant, 2025 · strength 0.45
- Lewis C. Cantley · 1 shared grant, 2025 · strength 0.45
- Sarah P. Thayer · 1 shared grant, 2025 · strength 0.45
- James wesley Horner · 1 shared grant, 2025 · strength 0.45
- Huamin Wang · 1 shared grant, 2025 · strength 0.45
- Tyler Jacks · 1 shared grant, 2025 · strength 0.45
- Jianhua Zhang · 2 shared papers, 2014–2024 · strength 0.17
- Jennifer Brooke Goldstein · 2 shared papers, 2018–2020 · strength 0.17
- Paper Germline DNA Sequencing Reveals Novel Mutations Predictive of Overall Survival in a Cohort of Patients with Pancreatic … DOI 10.1158/1078-0432.ccr-19-0224↗
- Paper High Prevalence of Hereditary Cancer Syndromes and Outcomes in Adults with Early-Onset Pancreatic Cancer. DOI 10.1158/1940-6207.capr-18-0014↗
- Gauri Rajani Varadhachary · 2 shared papers, 2018–2020 · strength 0.17
- Paper Germline DNA Sequencing Reveals Novel Mutations Predictive of Overall Survival in a Cohort of Patients with Pancreatic … DOI 10.1158/1078-0432.ccr-19-0224↗
- Paper High Prevalence of Hereditary Cancer Syndromes and Outcomes in Adults with Early-Onset Pancreatic Cancer. DOI 10.1158/1940-6207.capr-18-0014↗
- Florencia M. McAllister · 2 shared papers, 2018–2020 · strength 0.17
- Paper Germline DNA Sequencing Reveals Novel Mutations Predictive of Overall Survival in a Cohort of Patients with Pancreatic … DOI 10.1158/1078-0432.ccr-19-0224↗
- Paper High Prevalence of Hereditary Cancer Syndromes and Outcomes in Adults with Early-Onset Pancreatic Cancer. DOI 10.1158/1940-6207.capr-18-0014↗
- David R. Fogelman · 2 shared papers, 2018–2020 · strength 0.17
- Paper Germline DNA Sequencing Reveals Novel Mutations Predictive of Overall Survival in a Cohort of Patients with Pancreatic … DOI 10.1158/1078-0432.ccr-19-0224↗
- Paper High Prevalence of Hereditary Cancer Syndromes and Outcomes in Adults with Early-Onset Pancreatic Cancer. DOI 10.1158/1940-6207.capr-18-0014↗
- Andrea Viale · 1 shared paper, 2024 · strength 0.13
- Francesca Citron · 1 shared paper, 2024 · strength 0.13
- Alessandro Carugo · 1 shared paper, 2024 · strength 0.13
- Virginia Giuliani · 1 shared paper, 2024 · strength 0.13
- Timothy Paul Heffernan · 1 shared paper, 2024 · strength 0.13
- I-Lin Ho · 1 shared paper, 2024 · strength 0.13
- Giannicola Genovese · 1 shared paper, 2024 · strength 0.13
- Ziheng Chen · 1 shared paper, 2024 · strength 0.13
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.